Epilepsy research opportunities

Epilepsy clinical trials recruiting in the United States

Explore currently listed epilepsy studies with reported U.S. locations, including research involving different seizure types and age groups. Compare age range, phase, sponsor, and public eligibility information before contacting an official study team.

8 recruiting studies 11 reported study locations

Find epilepsy studies near you

Enter a U.S. ZIP code to compare studies by distance from reported study sites.

Featured recruiting epilepsy studies

Age: 18 Years and olderPhase: NAReported sites: 2Sponsor: Mayo Clinic

The specific aim of this study is to compare simultaneous assessment of gastric emptying and gastric accommodation in response to a caloric meal In patients who have previously undergone activation of left cervical VNS for the treatment of medication-resistant depression. Our hypothesis is that cervical VNS increases gastric accommodation and accelerates gastric emptying compared to a bank of healthy control data.

Age: 18 Years and olderPhase: NAReported sites: 2Sponsor: University of Southern California

Neuropsychiatric disorders are a leading cause of disability worldwide with depressive disorders being one of the most disabling among them. Also, millions of patients do not respond to current medications or psychotherapy, which makes it critical to find an alternative therapy. Applying electrical stimulation at various brain targets has shown promise but there is a critical need to improve efficacy. Given inter- and intra-subject variabilities in neuropsychiatric disorders, this study aims to enable…

Age: 18 Years – 99 YearsPhase: NAReported sites: 1Sponsor: NYU Langone Health

This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are 8-week programs delivered in one-hour weekly sessions to groups of about 6 participants. Changes in depressive symptoms, quality of life and seizures will be assessed over 12 months. The trial will also examine…

Age: 18 Years – 65 YearsPhase: NAReported sites: 1Sponsor: Stanford University

Transcranial magnetic stimulation (TMS) is an effective treatment for depression, but clinical outcome is suboptimal, partially because investigators are missing biologically-grounded brain markers which show that TMS is modifying activity at the intended target in the brain. The goal of this proposal is to characterize the key markers of the brain's response to repeated doses of TMS with high resolution using invasive brain recordings in humans, and relate these brain markers to noninvasive recordings. These…

Age: Not reportedPhase: Not ApplicableReported sites: 1Sponsor: Sanford Health

The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts. Through partnerships with patient advocacy organizations and researchers worldwide, CoRDS helps connect rare disease communities…

Age: 21 Years and olderPhase: NAReported sites: 1Sponsor: Baylor College of Medicine

Depression is one of the most common disorders of mental health, affecting 7-8% of the population and causing tremendous disability to afflicted individuals and economic burden to society. In order to optimize existing treatments and develop improved ones, the investigators need a deeper understanding of the mechanistic basis of this complex disorder. Previous work in this area has made important progress but has two main limitations. (1) Most studies have used non-invasive and therefore imprecise measures of…

Age: 22 Years and olderPhase: NAReported sites: 1Sponsor: Baylor College of Medicine

The overall goal of this study is to map the spatiotemporal dynamics of social affective processing and to examine selective modulation of these dynamics in humans undergoing invasive intracranial monitoring for treatment-resistant epilepsy and depression. Pursuing this signal from a novel platform with invasive intracranial recording electrodes provides much-needed spatial and temporal resolution to characterize the neural dynamics of socio-affective processing. The investigators will leverage first-in-human…

What eligibility can depend on

Each protocol is different. Study teams may consider diagnosis details, disease characteristics, prior treatments, age, general health, and the ability to attend required visits.

Before contacting a study

Review the official listing and consider having your diagnosis and treatment history available. Only the study team can confirm whether a trial may be appropriate.

Questions to ask

Ask about the study purpose, procedures, possible risks and benefits, visit schedule, travel, costs, and whether reimbursement is available.

Important: Varda Clinical is an independent discovery tool. It does not provide medical advice, recommend treatment, or determine eligibility. Verify study details with the official research team and discuss participation with a qualified healthcare professional.